Paulson Notes Detour’s Continued Entrenchment and Insider

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
Paulson Notes Detour’s Continued Entrenchment and Insider Selling
  • Detour Board forces shareholders to wait five months to vote on new board
  • Paulson alarmed at insiders selling of more than $2.3 million worth of shares in July days after touting an unrealistic plan to deliver long-term value

NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Paulson & Co. Inc. (“Paulson”) criticized the decision by the Board of Directors of Detour Gold Corporation (TSX: DGC) ("Detour Gold" or the "Company”) to force shareholders to wait until December 11 before being able to vote on a new independent Board.  The latest entrenchment tactic impedes and delays Paulson’s efforts to hold the Board accountable for ongoing substantial value destruction.  Many significant shareholders have publicly endorsed replacing directors.

“It is inexcusable that the Board delayed the meeting and refused to hold itself accountable to shareholders,” said Marcelo Kim, a Partner at Paulson. “Detour shareholders will finally have an opportunity to end the protracted destruction in shareholder value suffered at the hands of this Board.  The incumbent directors have approved three life of mine plans in three years, each with worsening economics, revealing they are unqualified to question underlying assumptions and evaluate the risks associated with running a world class mine.”

Insiders Selling Shares
Recently and revealingly, insiders questionably exercised options and sold shares, preferring to line their pockets with cash instead of investing along-side with shareholders.  Seven insiders traded and sold 188,427 shares, worth $2,375,767 in the Company starting late July.  These actions demonstrate that the insiders have no confidence in their own plan and serve to highlight the perpetual misalignment of incentives with shareholders.  Paulson, which has been a shareholder in Detour Gold since 2009, has not sold any shares in the Company since January 2017.

Interim Chief Executive Officer Michael Kenyon sold more than $1 million worth of stock days after stating: “we remain firm in our belief that the actions we are taking will deliver long-term value to our shareholders.” The magnitude of share sales by so many insiders, coupled with their already minimal holdings in Detour Gold, is a shocking betrayal to investors who have held the stock only to see the value of it drop significantly.

Questionable Meeting Practices
The voting results from the May 2018 Detour Gold meeting of shareholders are questionable. The Company’s disclosure of revisions to its 2017 Life of Mine plan was made so late in the proxy voting process many shareholders had already voted.  Paulson is concerned that the Company may try to employ similar tactics to try and manipulate the upcoming meeting through procedural tactics, such as “vote buying”, where brokers are paid for shareholder votes they submit.  However, Paulson will continue to explore all options to ensure that this meeting is held in a fair and timely manner for the benefit of all shareholders.

Paulson previously announced the candidates that will stand for election to the Detour Gold Board of Directors and will file a proxy circular in due course.

Annex
The following table highlights recent Detour Gold insider trading and share sales:

NameDate Options ExercisedExercise Price Shares SoldPriceProceeds
Drew Anwyll
Senior Officer
July 3033,000$10.5333,000$12.54$413,820
Robert Doyle1
Director
July 3112,500$10.5312,500$12.82$160,251
Laurence Gaborit
Senior Officer
July 306,000$10.536,000$12.63$75,780
Francis Heredia
Senior Officer
July 3027,000$3.9327,000$12.58$339,660
July 303,600$10.533,600$12.57$45,252
Michael Kenyon
Director and
Senior Officer
Aug. 890,000$10.5382,927$12.73$1,055,660
James Mavor
Senior Officer
Aug. 98,000$10.538,000$12.30$98,400
Aug. 136,400$10.536,400$11.33$72,512
Jonathan Rubenstein
Director
Aug. 39,000$10.539,000$12.71$114,432
TOTAL   188,427 $2,375,767
       

[1] Mr. Doyle’s SEDI form appears to show he did not sell any of the Common Shares underlying his Options, however, it lists a unit price of $12.8201 for his exercise of Options. Based on this, it is highly probable he actually sold the Common Shares he received but made an error with his form. The table includes information as if he did in fact sell his underlying Common Shares.

The information contained in this news release does not and is not meant to constitute a solicitation of a proxy within the meaning of applicable securities laws. Shareholders are not being asked at this time to execute a proxy in favour of the Paulson nominees. In connection with the December 11 meeting (for which there is not yet a record date), Paulson may file and mail a dissident information circular in due course in compliance with applicable securities laws.

A copy of this news release may be obtained on Detour Gold's SEDAR profile at www.sedar.com.

About Paulson & Co. Inc.

Paulson is one of Detour Gold’s most important investors, exercising control or direction over approximately 5.4% of Detour Gold’s shares. Having first invested in the Company nine years ago, Paulson previously provided C$280 million in direct equity and US$250 million in convertible notes to finance its mine completion. Paulson, along with several other major shareholders in the Company, has grown increasingly frustrated by the Company’s inability to appropriately manage shareholders’ assets, having destroyed billions of dollars of value in the process.

Paulson, founded in 1994, is an investment management firm with offices located in New York, London and Dublin.

Contact Details

Investors:
MacKenzie Partners, Inc.
Dan Burch & Jeanne Carr
800-322-2885

Media:
Longview Communications & Public Affairs
Peter Block
416-649-8008

Joel Shaffer
416-649-8006

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 1

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 5

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 0

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Rznomics Unveils Breakthrough in Circular RNA Production

Updated Category News Views 0

Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...

Continue Reading

Top 5 Most Recently Viewed Articles

Toll Brothers Reveals Fourth Quarter Success and Growth Strategy

Updated Category News Views 173

Toll Brothers' Impressive Fourth Quarter Results Toll Brothers, Inc. (NYSE: TOL) is proud to announce its financial results for the fourth quarter, showcasing the strength of the luxury home building sector. The company focused on delivering homes that meet the needs of its clients while navigating a challenging economic environment. Quarterly Financial Highlights The...

Continue Reading
Gevo Expands Sustainable Energy Portfolio with New Acquisition

Updated Category News Views 171

Gevo Advances Its Renewable Energy Strategy Gevo, Inc. (NASDAQ: GEVO), a leading innovator in the production of sustainable hydrocarbon fuels and chemicals, has recently acquired the assets of Red Trail Energy. This includes an ethanol production facility and carbon capture and sequestration (CCS) technologies, marking a significant milestone in Gevo's strategic...

Continue Reading
Swipesum and Facility Ally Transform Eating and Sports Payments

Updated Category News Views 156

Revolutionizing Payment Solutions in the Event Space ST. LOUIS -- In an exciting move for the world of payment processing, Swipesum, a frontrunner in merchant services consultancy, has announced a strategic partnership with Facility Ally, a notable provider of business solutions tailored for sports and entertainment venues. Their collaborative endeavor is set to redefine...

Continue Reading
Investors Unite: Join the PACS Lawsuit for Justice

Updated Category News Views 140

PACS Group, Inc. Investors Encouraged to Act Attorney Advertising -- A significant opportunity has arisen for investors of PACS Group, Inc. to stand up for their rights in a class action lawsuit. The law firm Bronstein, Gewirtz & Grossman, LLC has filed this crucial case against PACS Group and a number of its officers, aiming to address substantial losses incurred by...

Continue Reading
US Equities Preparing for a Strong Finish Amid Positive Trends

Updated Category News Views 104

Market Trends Shaping US Equities As we near the end of the second quarter earnings season, the reports from S&P 500 companies have been heartening. The overall earnings-per-share growth is currently at 11.8% year-over-year, reflecting a vigorous economic backdrop. Such growth indicates that many businesses are thriving, continuing a trend that saw 81% of the companies...

Continue Reading